A round-up of the latest appointments in Europe's consumer health industry: Orkla Health names BioGaia's Ducellier as its CEO; PAGB makes changes to its board; and Afepadi names Uriach's Gispert as its president.

Dermapharm has high hopes for 2023 as its acquisition of Arkopharma means the firm is now the number-one and number-three player respectively in the French and Spanish supplements markets.

Schwabe is looking to take a slice of Brazil's growing herbal medicines market by teaming up with local player Herbarium to launch a new joint venture in 2024.

A round-up of the latest appointments in the consumer health industry: the Global Self-Care Federation elects J&J's Raghunandanan as its chair; Bayer Consumer Health makes changes to its medical leadership; and Shop Apotheke hires ex-DocMorris CEO to lead company.

When investigated for promoting apple cider vinegar as a treatment for a myriad of ailments, from lowering cholesterol to preventing colds and flu, UK-based Willy's told the country's advertising regulator that trials to substantiate these claims were "prohibitively expensive."

France's Laboratoire Lescuyer can now claim its Limicol botanical extract supplement "reduces blood LDL-cholesterol concentrations" after waiting more than 10 years for approval by the European Commission.